Multiple Sclerosis Journal · 2024 · 32 citations · 16 references
MedicineNeurologyNeuroscienceClinical NeuroscienceCognitive NeurologyFunctional DeclineCognitive DeclineCognitive ImpairmentCognitive SymptomsMultiple SclerosisNeurodegenerative DiseasesRelapsed DiseaseCognitive Activity ProgressionCognitive ProgressionLongitudinal Cognitive DeclineMultiple Sclerosis Cognition
Background: Substantial physical-disability worsening in relapsing-remitting multiple sclerosis (RRMS) occurs outside of clinically recorded relapse. This phenomenon, termed progression independent of relapse activity (PIRA), is yet to be established for cognitive decline. Methods: Retrospective analysis of RRMS patients. Cognitive decline was defined using reliable-change-index cut-offs for each test (Symbol Digit Modalities Test, Brief Visuospatial Memory Test–Revised, California Verbal Learning Test–II). Decline was classified as PIRA if the following conditions were met: no relapse observed between assessments nor within 9 months of cognitive decline. Results: The study sample ( n = 336) was 80.7% female with a mean (standard deviation (SD)) age, disease duration, and observation period of 43.1 (9.5), 10.8 (8.4), and 8.1 (3.1) years, respectively. A total of 169 (50.3%) subjects were cognitively impaired at baseline relative to age-, sex-, and education-matched HCs. Within subjects who experienced cognitive decline ( n = 167), 89% experienced cognitive PIRA. A total of 141 (68.1%) cognitive decline events were observed independent of EDSS worsening. Cognitive PIRA was more likely to be observed with increased assessments ( p < 0.001) and lower assessment density ( p < 0.001), accounting for baseline clinical factors. Conclusion: These results establish the concept of cognitive PIRA and further our understanding of progressive cognitive decline in RRMS.
16
How patients with multiple sclerosis acquire disability
Fred Lublin, Dieter A. Häring, Habib Ganjgahi et al. · Brain · 2022 · 528 citations · Full text
Silent progression in disease activity–free relapsing multiple sclerosis
Bruce Cree, Jill A. Hollenbach, Riley Bove et al. · Annals of Neurology · 2019 · 455 citations · Full text
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation
Ralph H. B. Benedict, Maria Pia Amato, Jan Boringa et al. · BMC Neurology · 2012 · 414 citations · Full text
Medicine, Neurology, Psychology +17
Carmen Tur, Pere Carbonell‐Mirabent, Álvaro Cobo‐Calvo et al. · JAMA Neurology · 2022 · 275 citations · Full text